Results 251 to 260 of about 8,424,075 (351)

Evaluation of synaptotagmin‐1 action models by all‐atom molecular dynamics simulations

FEBS Open Bio, EarlyView.
We used molecular dynamics simulations to test models proposing that synaptotagmin‐1 facilitates membrane fusion by perturbing lipid bilayers, inducing membrane curvature and/or bridging membranes. The simulations show that synaptotagmin‐1 C2‐domains placed near the site of fusion hinder the ability of SNARE complexes to bring the membranes together ...
Josep Rizo, Klaudia Jaczynska, Christian Rosenmund   +2 more
wiley   +1 more source

Multi-ancestry sequencing-based genome-wide association study of C-reactive protein in 513,273 genomes. [PDF]

Nat Commun
Li H, Zhao J, Dai J, You D, Zhao Y, Christiani DC, Chen F, Shen S.   +7 more
europepmc   +1 more source

Building a Solid Foundation: The Need for Causal Evidence Before Advancing Anti‐Obesity Drug Development Targeting the Endocannabinoid System

Andrej Belančić, Farideh Javid
openalex   +1 more source

FAM136A depletion induces mitochondrial stress and reduces mitochondrial membrane potential and ATP production

FEBS Open Bio, EarlyView.
FAM136A depletion upregulated ROS production, reduced mitochondrial membrane potential (ΔΨ) and ATP production, and upregulated expression of PCK1, PCK2, HMGCS1, and HMGCS2. The expression of both TOMM22 and TOMM20 was also upregulated. FAM136A depletion reduced HCCS that produce holocytochrome c by combining heme to apocytochrome c, and reduced the ...
Yushi Otsuka, Masato Yano
wiley   +1 more source

Clinically meaningful benefit and real-world evidence in Alzheimer's disease research and care. [PDF]

Alzheimers Dement (N Y)
Perneczky R, Froelich L.
europepmc   +1 more source

Pharmacological effects of osimertinib on a chicken chorioallantoic membrane xenograft model with the EGFR exon‐19‐deleted advanced NSCLC mutation

FEBS Open Bio, EarlyView.
Osimertinib reduces angiogenesis and PDL1 expression in in ovo tumors, transforming them into ‘cold tumors’ with lower immune activity. Anatomopathological and transcriptomic analyses highlight its therapeutic impact on tumor biology. This study underscores osimertinib's potential to reshape the tumor microenvironment and provides insights into its ...
David Barthélémy, Arnaud Vigneron, Xavier Rousset, Jérome Guitton, Emmanuel Grolleau, Margaux Raffin, Julie Balandier, Gaëlle Lescuyer, Mathilde Bardou, Florence Geiguer, Sébastien Couraud, Claire Bardel, Jean Viallet, Nazim Benzerdjeb, Léa Payen   +14 more
wiley   +1 more source

Thrombus rooting in the pulmonary arteriovenous fistula in a patient with cryptogenic stroke, a case report. [PDF]

BMC Neurol
Song M, Dai H, Lu W, Meng X.
europepmc   +1 more source

A decade of open access policy at the Gates Foundation based on experimentation, evidence and evolution

Ashley Farley
openalex   +1 more source

Identification of inhibitors of the Salmonella FraB deglycase, a drug target

FEBS Open Bio, EarlyView.
A high‐throughput screen was used to identify inhibitors of Salmonella FraB, a drug target. Characterization of top hits (identified after an additional counter screen) revealed that some triazolidines, thiadiazolidines, and triazolothiadiazoles are mixed‐type inhibitors of FraB.
Jamison D. Law, Yuan Gao, Sravya Kovvali, Pankajavalli Thirugnanasambantham, Vicki H. Wysocki, Brian M. M. Ahmer, Venkat Gopalan   +6 more
wiley   +1 more source

Comparative Analysis of AI Tools for Disseminating ADA 2025 Diabetes Care Standards: Implications for Cardiovascular Physicians. [PDF]

J Diabetes
Zheng T.
europepmc   +1 more source